Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4931]

Amivantamab, the first treatment approved for patients with advanced NSCLC with EGFR exon 20 insertion mutations after failure of platinum-based therapy

Amivantamab, the first treatment approved for patients with advanced NSCLC with EGFR exon 20 insertion mutations...

Investigator helps chart progress in clinical trial of patients with chemoresistant triple-negative breast cancer

Investigator helps chart progress in clinical trial of patients with chemoresistant triple-negative breast cancer

Repurposed drug shows improved results with combined therapy for triple negative breast cancer

Repurposed drug shows improved results with combined therapy for triple negative breast cancer

Researchers uncover how a virus transforms immune cells into cancer

Researchers uncover how a virus transforms immune cells into cancer

Surgical procedure helps cancer patients face themselves again

Surgical procedure helps cancer patients face themselves again

Creating a checklist for bringing oncogenomics in paediatrics into world healthcare systems

Creating a checklist for bringing oncogenomics in paediatrics into world healthcare systems

Inequalities in paediatric cancer care: A need for Action

Inequalities in paediatric cancer care: A need for Action

ASH 2021: New drug combo may improve family-donated stem cells as blood cancer treatment

ASH 2021: New drug combo may improve family-donated stem cells as blood cancer treatment

ASH 2021: Drug combination found to keep chronic lymphocytic leukaemia in young patients in remission for several years

ASH 2021: Drug combination found to keep chronic lymphocytic leukaemia in young patients in remission for several...

Nivolumab for the adjuvant treatment of oesophageal carcinoma

Nivolumab for the adjuvant treatment of oesophageal carcinoma

More from ecancer